Ceftolozane-tazobactam and Fosfomycin for rescue treatment of otogenous meningitis caused by XDR Pseudomonas aeruginosa: Case report and review of the literature-Reference-Cited by-同舟云学术

Ceftolozane-tazobactam and Fosfomycin for rescue treatment of otogenous meningitis caused by XDR Pseudomonas aeruginosa: Case report and review of the literature

Published:2018 Issue: Volume:14 Page:e00451
ISSN:2214-2509
Container-title:IDCases
language:en
Short-container-title:IDCases

Author:

Frattari Antonella,Savini Vincenzo,Polilli Ennio,Cibelli Donatella,Talamazzi Silvia,Bosco Donatella,Consorte Augusta,Fazii Paolo,Parruti Giustino

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference15 articles.

1. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology;Potron;Int J Antimicrob Agents,2015

2. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician;Martis;J Infect,2014

3. Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem;Morelli;J Antimicrob Chemother,2014

4. Pseudomonas aeruginosa meningitis/ventriculitis in a UK tertiary referral hospital;Pai;QJM,2016

5. Polymyxins for CNS infections: pharmacology and neurotoxicity;Velkov;Pharmacol Ther,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study;International Journal of Antimicrobial Agents;2024-08

2. Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections;Antibiotics;2023-11-23

3. Multimodal silver-chitosan-acylase nanoparticles inhibit bacterial growth and biofilm formation by Gram-negative Pseudomonas aeruginosa bacterium;Journal of Colloid and Interface Science;2023-09

4. Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa;Pharmaceuticals;2023-08-30

5. The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies;Expert Review of Anti-infective Therapy;2023-01-19